Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases.

Fornaro, Marco; Venerito, Vincenzo; Iannone, Florenzo; Cacciapaglia, Fabio

Fornaro, Marco; Venerito, Vincenzo; Iannone, Florenzo; Cacciapaglia, Fabio.

Fornaro M; Rheumatology Unit, Department of Emergency and Organ Transplantation, Bari, Italy.
Venerito V; Rheumatology Unit, Department of Emergency and Organ Transplantation, Bari, Italy.
Iannone F; Rheumatology Unit, Department of Emergency and Organ Transplantation, Bari, Italy. florenzo.iannone@uniba.it.
Cacciapaglia F; Rheumatology Unit, Department of Emergency and Organ Transplantation, Bari, Italy.

J Rheumatol ; 49(3): 334-335, 2022 03.

Article in English | MEDLINE | ID: covidwho-1625190

Subject(s)

COVID-19; Rheumatic Diseases; Antibodies, Viral; BNT162 Vaccine; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; RNA, Messenger; Recurrence; Rheumatic Diseases/drug therapy; SARS-CoV-2; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatic Diseases / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: J Rheumatol Year: 2022 Document Type: Article Affiliation country: Jrheum.210863

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google